Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 083220

Expand all

OGEN 5 (ESTROPIPATE)
6MG
Marketing Status: Prescription

Active Ingredient: ESTROPIPATE
Proprietary Name: OGEN 5
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 6MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: A083220
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PFIZER INC
Marketing Status:  Prescription
Patent and Exclusivity Information

OGEN .625 (ESTROPIPATE)
0.75MG
Marketing Status: Discontinued

Active Ingredient: ESTROPIPATE
Proprietary Name: OGEN .625
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.75MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: A083220
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PFIZER INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

OGEN 1.25 (ESTROPIPATE)
1.5MG
Marketing Status: Discontinued

Active Ingredient: ESTROPIPATE
Proprietary Name: OGEN 1.25
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: A083220
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PFIZER INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

OGEN 2.5 (ESTROPIPATE)
3MG
Marketing Status: Discontinued

Active Ingredient: ESTROPIPATE
Proprietary Name: OGEN 2.5
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 3MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: A083220
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PFIZER INC
Marketing Status:  Discontinued
Patent and Exclusivity Information